Mechanisms of viral entry: Sneaking in the front door

Protoplasma

Volumn 244, Issue 1, 2010, Pages 15-24

  Thorley, Jennifer A ^a   McKeating, Jane A ^a   Rappoport, Joshua Zachary ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Endocytic trafficking; Endocytosis; Host cells; Vesicle trafficking; Viral entry; Viruses

Indexed keywords

CLATHRIN;

ENDOCYTOSIS; HUMAN; METABOLISM; REVIEW; ULTRASTRUCTURE; VIRUS; VIRUS ENTRY;

CLATHRIN; ENDOCYTOSIS; HUMANS; VIRUS INTERNALIZATION; VIRUSES;

HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; POLIOVIRUS; SIMIAN VIRUS 40;

EID: 77955770216     PISSN: 0033183X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00709-010-0152-6     Document Type: Review

References (120)

1. Anderson HA et al (1996) Bound simian virus 40 translocates to caveolin-enriched membrane domains, and its entry is inhibited by drugs that selectively disrupt caveolae. Mol Biol Cell 7(11): 1825-1834.
2. Bartosch B et al (2003a) Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor. J Biol Chem 278: 41624-41630.
3. Bartosch B et al (2003b) Infectious hepatitis C virus Pseudo-particles containing functional E1-E2 envelope protein complexes. J Exp Med 197(5): 633-642.
4. Bartosch B et al (2003c) In vitro assay for neutralizing antibody to hepatitis C virus: evidence for broadly conserved neutralization epitopes. Proc Natl Acad Sci U S A 100(24): 14199-14204.
5. Bartosch B, Cosset FL (2006) Cell entry of hepatitis C. Virology 348(1): 1-12.
6. Bergelson JM et al (1997) Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science 275(5304): 1320.
7. Blanchard E et al (2006) Hepatitis C virus entry depends on clathrin-mediated endocytosis. J Virol 80(14): 6964-6972.
8. Brandenburg B et al (2007) Imaging poliovirus entry in live cells. PLoS Biol 5(7): 1543-1555.
9. Breau WC et al (1992) Class I major histocompatibility proteins are an essential component of the simian virus 40 receptor. J Virol 66(4): 2037-2045.
10. Broder C, Dimitrov DS (1996) HIV and the 7-transmembrane domain receptors. Pathobiology 64(4): 171-179.
11. Brown T, Burlingham BT (1973) Penetration of host cell membranes by adenovirus 2. D J Virol 12(2): 386-396.
12. Burkly L et al (1992) Inhibition of HIV infection by a novel CD4 domain 2-specific monoclonal antibody. Dissecting the basis for its inhibitory effect on HIV-induced cell fusion. J Immunol 149: 1779-1787.
13. Burkly L et al (1995) Synergistic inhibition of human immunodeficiency virus type 1 envelope glycoprotein-mediated cell fusion and infection by an antibody to CD4 domain 2 in combination with anti-gp120 antibodies. J Virol 69: 4267-4273.
14. Carroll SM et al (1981) Different cell-surface receptor determinants of antigenically similar influenza virus hemagglutinins. J Biol Chem 256(16): 8357-8363.
15. Catanese MT et al (2010) Role of scavenger receptor class B type I in hepatitis C virus entry: kinetics and molecular determinants. J Virol 84: 34-43.
16. Chambers P et al (1990) Heptad repeat sequences are located adjacent to hydrophobic regions in several types of virus fusion glycoproteins. J Gen Virol 71(12): 3075-3080.
17. Chan DC et al (1997) Core structure of gp41 from the HIV envelope glycoprotein. Cell 89(2): 263-273.
18. Clotet B et al (2007) Efficacy and safety of darunavir-ritonavir at week 48 in treatment-experienced patients with HIV-1 infection in POWER 1 and 2: a pooled subgroup analysis of data from two randomised trials. Lancet 369: 1169-1178.
19. Cohen FS et al (1984) Parameters affecting the fusion of unilamellar phospholipid vesicles with planar bilayer membranes. J Cell Biol 98(3): 1054-1062.
20. Coller KE et al (2009) RNA interference and single particle tracking analysis of hepatitis C virus endocytosis. PLoS Pathogens 5(12): e1000702.
21. Cormier EG et al (2004) CD81 is an entry coreceptor for hepatitis C virus. Proc Natl Acad Sci U S A 101: 7270-7274.
22. Coyne CB, Bergelson JM (2005) CAR: a virus receptor within a tight junction. Adv Drug Deliv Rev 57(6): 869-882.
23. Coyne CB, Bergelson JM (2006) Virusinduced Abl and Fyn kinase signals permit coxsackievirus entry through epithelial tight junctions. Cell 124(1): 119-131.
24. Coyne CB et al (2007) Coxsackievirus entry across epithelial tight junctions requires occludin and the small GTPases Rab34 and Rab5. Cell Host Microbe 2(3): 181-192.
25. Coyne CB et al (2009) The distinct roles of JAM-A in reovirus pathogenesis. Cell Host Microbe 5(1): 3-5.
26. Daecke J et al (2005) Involvement of clathrin-mediated endocytosis in human immunodeficiency virus type 1 entry. J Virol 79(3): 1581-1594.
27. Dalgleish AG et al (1984) The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 312(5996): 763-767.
28. Damm E-M et al (2005) Clathrin and Caveolin-1- independent endocytosis: entry of simian virus 40 into cells devoid of caveolae. JCB 168(3): 477-488.
29. Dangoria NS et al (1996) Extracellular simian virus 40 induces and ERK/MAP kinase-independent signalling pathway that activates primary response genes and promotes virus entry. J General Virol 77: 2173-2182.
30. Day PM et al (2003) Papillomaviruses infect cells via a clathrin-dependent pathway. Virology 307(1): 1-11.
31. Deng H et al (1996) Identification of a major co-receptor for primary isolates of HIV-1. Nature 381(6584): 661-666.
32. Doms RW, Helenius A (1986) Quarternary structure of influenza virus hemagglutinin after acid treatment. J Virol 60(3): 833-839.
33. Dourmashkin RR, Tyrrell TA (1974) Electron microscopic observations on the entry process of influenza virus into susceptible cells. J Gen Virol 24(1): 129-141.
34. Dragic T et al (1996) HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature 381(6584): 667-673.
35. Drummer HE et al (2003) Cell surface expression of functional hepatitis C virus E1 and E2 glycoproteins. FEBS Lett 546(2-3): 385-390.
36. Dunnebacke TH et al (1969) Entry and release of poliovirus as observed by electron microscopy of cultured cells. J Virol 4: 505-513.
37. Evans MJ et al (2007) Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry. Nature 446: 801-805.
38. Feng Y et al (1996) HIV-1 entry co-factor: functional cDNA cloning of a seven-transmembrane G-protein coupled receptor. Science 272(5263): 872-877.
39. Flint M et al (2006) Diverse CD81 proteins support hepatitis C virus infection. J Virol 80: 11331-11342.
40. Fredericksen BL et al (2002) Inhibition of endosomal/lysosomal degradation increases the infectivity of human immunodeficiency virus. J Virol 76(22): 11440-11446.
41. Gastaldelli M et al (2008) Infectious adenovirus type 2 transport through early but not late endosomes. Traffic 9: 2265-2278.
42. Gilbert JM et al (2003) Cell penetration and trafficking of polyomavirus. J Virol 77(4): 2615-2622.
43. Glenn GM, Eckhart W (1990) Transcriptional regulation of early-response genes during polyomavirus infection. J Virol 64(5): 2193-2201.
44. Grewe C et al (1990) HIV: early virus-cell interactions. J Acquir Immune Defic Syndr 3(10): 965-974.
45. Greber UF et al (1993) Stepwise dismantling of adenovirus 2 during entry into cells. Cell 75(3): 477-486.
46. Grove J et al (2007) Scavenger receptor BI and BII expression levels modulate hepatitis C virus infectivity. J Virol 81: 3162-3169.
47. Guinea R, Cerrasco L (1994) Concanamycin a blocks influenza virus entry into cells under acidic conditions. FEBBS Lett 349(3): 327-330.
48. Guinea R, Cerrasco L (1995) Requirement for vacuolar proton-atpase activity during entry of influenza virus into cells. J Virol 69(4): 2306-2312.
49. Guo Q et al (2003) (2003) Biochemical and genetic characterizations of a novel human immunodeficiency virus type 1 inhibitor that blocks gp120-CD4 interactions. J Virol 77: 10528-10536.
50. Harris HJ et al (2008) CD81 and claudin 1 coreceptor association: role in hepatitis C virus entry. J Virol 82(10): 5007-5020.
51. Helle F, Dubuisson J (2008) Hepatitis C virus entry into host cells. Cell Mol Life Sci 65(1): 100-112.
52. Hicks CB et al (2006) Durable efficacy of tipranavir-ritonavir in combination with an optimised background regimen of antiretroviral drugs for treatment-experienced HIV-1-infected patients at 48 weeks in the Randomized Evaluation of Strategic Intervention in multi-drug reSistant patients with Tipranavir (RESIST) studies: an analysis of combined data from two randomised open-label trials. Lancet 368: 466-475.
53. Hsu M et al (2003) Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles. Proc Natl Acad Sci U S A 100(12): 7271-7276.
54. Hummeler K et al (1970) Morphological aspects of the uptake of simian virus 40 by permissive cells. J Virol 6(1): 87-93.
55. Kawase M et al (2009) Protease-mediated entry via the endosome of human coronavirus 229E. J Virol 83(2): 712-721.
56. Keck ZY et al (2004) Human monoclonal antibody to hepatitis C virus E1 glycoprotein that blocks virus attachment and viral infectivity. J Virol 78(13): 7257-7263.
57. Kirkham M, Parton RG (2005) Clathrin-independent endocytosis: new insights into caveolae and non-caveolar lipid raft carriers. Biochim Biophys Acta 1745(3): 273-286.
58. Kuritzkes DR et al (2004) Antiretroviral activity of the anti-CD4 monoclonal antibody TNX-355 in patients infected with human immunodeficiency virus type 1. J Infect Dis 189: 286-291.
59. Kuritzkes DR (2009) HIV-1 entry inhibitors: an overview. Curr Opin HIV AIDS 4(2): 82-87.
60. Lakadamyali M et al (2004) Endocytosis of influenza viruses. Microbes Infect 6: 929-936.
61. Lalezari JP et al (2003) Enfuvirtide, an HIV-1 fusion inhibitor, for drug-resistant HIV infection in North and South America. N Engl J Med 348: 2175-2185.
62. Lee KK (2010) Architecture of a nascent viral fusion pore. EMBO J 29(7): 1299-1311.
63. Leon RP et al (1998) Adenoviral-mediated gene transfer in lymphocytes. Proc Natl Acad Sci U S A 95(22): 13159-13164.
64. Liebl D et al (2006) Mouse polyomavirus enters early endosomes, requires their acidic pH for productive infection, and meets transferrin cargo in Rab11-positive endosomes. J Virol 80(9): 4610-4622.
65. Lin PF et al (2003) A small molecule HIV-1 inhibitor that targets the HIV-1 envelope and inhibits CD4 receptor binding. Proc Natl Acad Sci U S A 100: 11013-11018.
66. Lindenbach BD et al (2005) Complete replication of hepatitis C virus in cell culture. Science 309(5734): 623-626.
67. Liu S et al (2009) Tight junction proteins claudin-1 and occludin control hepatitis C virus entry and are downregulated during infection to prevent superinfection. J Virol 83: 2011-2014.
68. Maddon PJ et al (1988) HIV Infection does not require endocytosis of its receptor, CD4. Cell 54(6): 865-874.
69. Madshus IH et al (1984a) Requirements for entry of poliovirus RNA into cells at low pH. EMBO J 3(9): 1945-1950.
70. Madshus IH et al (1984b) Mechanism of entry into the cytosol of poliovirus type 1: requirement for low pH. J Cell Biol 98(4): 1194-1200.
71. Matlin KS et al (1981) Infectious entry pathway of influenza virus in a canine kidney cell line. J Cell Biol 91(3pt1): 601-613.
72. Maul GG et al (1978) Membrane fusion as a mechanism of simian virus 40 entry into different cellular compartments. J Virol 28(3): 936-944.
73. McKeating JA et al (2004) Diverse hepatitis C virus glycoproteins mediate viral infection in a CD81-dependent manner. J Virol 78(16): 8496-8505.
74. Meertens L et al (2006) Hepatitis C virus entry requires a critical postinternalization step and delivery to early endosomes via clathrin-coated vesicles. J Virol 80(23): 11571-11578.
75. Meier O et al (2002) Adenovirus triggers macropinocytosis and endosomal leakage together with its clathrin-mediated uptake. J Cell Biol 158(6): 1119-1131.
76. Meier O, Greber UF (2004) Adenovirus endocytosis. J Gene Med 6(Suppl 1): S152-S163.
77. Miyauchi K et al (2009) HIV enters cells via endocytosis and dynamin-dependent fusion with endosomes. Cell 137: 433-444.
78. Nomura R et al (2004) Human coronavirus 229E binds to CD13 in rafts and enters the cell through caveolae. J Virol 78(16): 8701-8708.
79. Norkin LC et al (2002) Caveolar endocytosis of simian virus 40 is followed by brefeldin A-sensitive transport to the endoplasmic reticulum, where the virus disassembles. J Virol 76(10): 5156-5166.
80. Nunes-Correia I et al (2004) Caveolae as an additional route for influenza virus endocytosis in MDCK cells. Cell Mol Biol Lett 9(1): 47-60.
81. Op De Beeck A et al (2004) Characterisation of functional hepatitis C virus envelope glycoproteins. J Virol 78(6): 2994-3002.
82. Patel KP et al (2009) Dynamin- and lipid raft-dependent entry of decay-accelerating factor (DAF)-binding and non-DAF-binding coxsackieviruses into nonpolarized cells. J Virol 83(21): 11064-11077.
83. Pauza CD, Price TM (1988) Human immunodeficiency virus infection of T cells and monocytes proceeds via receptor-mediated endocytosis. J Cell Biol 107(3): 959-968.
84. Pauza CD et al (1988) Human immunodeficiency virus infection of T cells and monocytes proceeds via receptor-mediated endocytosis. J Cell Biol 107(3): 959-968.
85. Pelkmans L et al (2001) Caveolar endocytosis of simian virus 40 reveals a new two-step vesicular- transport pathway to the ER. Nat Cell Biol 3: 473-483.
86. Pelkmans L et al (2002) Local actin polymerization and dynamin recruitment in SV40-induced internalization of caveolae. Science 296: 535-538.
87. Pileri P et al (1998) Binding of hepatitis C virus to CD81. Science 282: 938-941.
88. Ploss A et al (2009) Human occludin is a hepatitis C virus entry factor required for infection of mouse cells. Nature 457: 882-886.
89. Reynolds GM et al (2008) Hepatitis C virus receptor expression in normal and diseased liver tissue. Hepatology 47(2): 418-427.
90. Richterová Z et al (2001) Caveolae are involved in the trafficking of mouse polyomavirus virions and artificial VP1 pseudocapsids toward cell nuclei. J Virol 75(22): 10880-10891.
91. Roy AM et al (2000) Early stages of influenza virus entry into MV-1 lung cells: involvement of dynamin. Virology 267(1): 1728.
92. Rust MJ et al (2004) Assembly of endocytic machinery around individual influenza viruses during viral entry. Nat Struct Mol Biol 11(6): 567-573.
93. Samson M et al (1996) Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 382(6593): 722-725.
94. Sandvig K, Olsnes S (1980) Diphtheria toxin entry into cells is facilitated by low pH. J Cell Biol 87(3pt1): 828-832.
95. Sarkar DP et al (1989) Initial stages of influenza hemagglutinin-induced cell fusion monitored simultaneously by two fluorescent events: cytoplasmic continuity and lipid mixing. J Cell Biol 109(1): 113-122.
96. Scarselli E et al (2002) The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus. EMBO J 21: 5017-5025.
97. Schaeffer E et al (2004) Compensatory link between fusion and endocytosis of human immunodeficiency virus type 1 in human CD4 T lymphocytes. J Virol 78(3): 1375-1383.
98. Schelhaas M et al (2007) Simian virus 40 depends on ER protein folding and quality control factors for entry into host cells. Cell 131(3): 516-529.
99. Sieczkarski SB, Whittaker GR (2003) Differential requirements of Rab5 and Rab7 for endocytosis of influenza and other enveloped viruses. Traffic 4(5): 333-343.
100. Stehle T, Harrison SC (1996) Crystal structures of murine polyomavirus in complex with straight-chain and branched-chain sialyloligosaccharide receptor fragments. Structure 4(2): 183-194.
101. Stein BS et al (1987) pH-independent HIV entry into CD4-positive T cells via virus envelope fusion to the plasma membrane. Cell 49(5): 659-668.
102. Svensson U (1985) Role of vesicles during adenovirus 2 internalization into HeLa cells. J Virol 55(2): 442-449.
103. Tan K et al (1997) Atomic structure of a thermostable subdomain of HIV-1 gp41. Proc Natl Acad Sci U S A 94: 12303-12308.
104. Tscherne DM et al (2006) Time- and temperature-dependent activation of hepatitis C virus for low-pH-triggered entry. J Virol 80(4): 1734-1741.
105. Varga MJ (1991) Infectious entry pathway of adenovirus type 2. J Virol 65(11): 6061-6070.
106. Voss T et al (2008) Peptide-based entry inhibitors for influenza. Antivir Res 78(2): A18.
107. Wakita T et al (2005) Production of hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 11(7): 791-796.
108. Wang K et al (1998) Adenovirus internalization and infection require dynamin. J Virol 72(4): 3455-3458.
109. Wei BL et al (2005) Inhibition of lysosome and proteasome function enhances human immunodeficiency virus type 1 infection. J Virol 79(9): 5705-5712.
110. Weiss W et al (1988) Structure of the influenza virus haemagglutinin complexed with its receptor, sialic acid. Nature 333: 426-431.
111. Weissenhorn W et al (1997) Atomic structure of the ectodomain from HIV-1 gp41. Nature 387: 426-430.
112. Wickham TJ et al (1993) Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment. Cell 73(2): 309-319.
113. Wild CT et al (1994) Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection. Proc Natl Acad Sci U S A 91: 9770-9774.
114. Yamaya M et al (2010) Clarithromycin inhibits type A seasonal influenza virus infection in human airway epithelial cells. J Pharmacol Exp Ther 333(1): 81-90.
115. Yang W et al (2008) Correlation of the tight junction-like distribution of Claudin-1 to the cellular tropism of hepatitis C virus. J Biol Chem 283: 8643-8653.
116. Yoshimura A et al (1982) Infectious cell entry mechanism of influenza virus. J Virol 43(1): 284-293.
117. Yu YG et al (1994) Insertion of a coiled-coil peptide from influenza virus hemagglutinin into membranes. Science 266(5183): 274-276.
118. Zheng A et al (2007) Claudin-6 and claudin-9 function as additional coreceptors for hepatitis C virus. J Virol 81: 12465-12471.
119. Zhong J et al (2005) Robust hepatitis C virus infection in vitro. Proc Natl Acad Sci U S A 102(26): 9294-9299.
120. Zullo J et al (1987) Regulation of c-myc and c-fos mRNA levels by polyomavirus: distinct roles for the capsid protein VP1 and the viral early proteins. Proc Natl Acad Sci U S A 84(5): 1210-1214.